Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 54th Annual Meeting of the American Society of Hematology
Emerging Concepts in the Management of Iron Deficiency Anemia
Atlanta, Georgia / December 8-11, 2012
Atlanta - It is estimated that as many as 1.6 billion people have iron deficiency anemia (WHO Global Database on Anaemia. 2008;1-40, WHO anaemia fact sheet. 2001;114). Oral iron remains the preferred first-line treatment for iron deficiency...
PRIORITY PRESS - 54th Annual Meeting of the American Society of Hematology
Improving Overall Survival in Multiple Myeloma: Treatment Strategies and Regimens
Atlanta, Georgia / December 8-11, 2012
Atlanta - New data released at the 2012 American Society of Hematology (ASH) meeting further linked novel combinations with improved survival across multiple stages of multiple myeloma (MM). Given the relapsing/remitting nature of the...
PRIORITY PRESS - 64th Annual Meeting of the National Hemophilia Foundation
Hemophilia Management: Evaluating RICE and Factor Replacement Therapy with Longer Half-life
Orlando, Florida / November 8-10, 2012
Orlando - Conservative therapy in the management of joint and muscle bleeding in patients with hemophilia has consisted primarily of interventions known collectively as RICE: rest, ice, compression and elevation. A critical assessment of...
PRIORITY PRESS - 2012 Kidney Week of the American Society of Nephrology (ASN)
Options for Iron Correction and Erythropoiesis Stimulation: Better Benefit:Risk Through Individualized Therapy
San Diego, California / October 30 - November 4, 2012
San Diego - More sophisticated strategies for the treatment of anemia in patients with chronic kidney disease (CKD), including those on dialysis, are being driven by new options for replenishing iron and stimulating erythropoiesis. The...
MEDICAL FRONTIERS - 17th Congress of the European Hematology Association
Iron Chelation in Hematological Disorders: Emerging Data on Non-Transfusion-Dependent Thalassemia and Myelodysplastic Syndrome
Amsterdam, The Netherlands / June 14-17, 2012
Amsterdam - Iron overload is a complication found in a range of hematological disorders. While it is most strongly associated with transfusion dependence, it can also result from the disease process itself, notably in...
PRIORITY PRESS - 22nd European Congress on Clinical Microbiology and Infectious Diseases (ECCMID)
Primary Treatment of Invasive Aspergillosis in Hematology Patients
London, UK / March 31- April 3, 2012
London - The first randomized study of combination therapy in the treatment of invasive aspergillosis (IA) has provided new evidence-based guidance for hematological malignancy patients, including allograft hematopoietic stem cell...
MEDICAL FRONTIERS - 6th International Conference on Thrombosis and Hemostasis Issues in Cancer
Treatment and Prevention of Venous Thrombosis in Cancer
Bergamo, Italy / April 20-22, 2012
Bergamo - Cancer is a hypercoagulable state where malignancy heightens thrombotic risk throughout the course of active disease, especially during metastases. Anti-angiogenic chemotherapy agents can significantly increase embolic risk, as...
PRIORITY PRESS - 53rd Annual Meeting & Exposition of the American Society of Hematology
Enduring Survival Advantages of Novel Therapies for Transplant-ineligible Multiple Myeloma Patients
San Diego, California / December 10-13, 2011
San Diego - Prior to the introduction of proteasome inhibitors and immunomodulating agents for multiple myeloma (MM), the median survival for patients older than age 65 was <3 years. Five years after randomization, a 3-drug regimen with...
MEDICAL FRONTIERS - 53rd Annual Meeting & Exposition of the American Society of Hematology
Iron Chelation Associated with Improved Survival in Diverse Hematologic Disorders
San Diego, California / December 10-13, 2011
San Diego - New data presented during the 2011 ASH meeting have strengthened the evidence that iron chelation improves survival in patients with diseases involving dysfunctional red blood cells (RBCs). The data are particularly strong for...